TI
SNDX icon

Trexquant Investment’s Syndax Pharmaceuticals SNDX Stock Holding History

Trexquant Investment’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.6M Buy
255,949
+54,172
+27% +$1.13M 0.03% 696
2026
Q1 		$4.71M Buy
201,777
+114,263
+131% +$2.48M 0.03% 672
2025
Q4 		$1.84M Buy
+87,514
New +$1.53M 0.02% 1016
2025
Q2 		– Sell
-386,263
Closed -$4.75M – 1850
2025
Q1 		$4.75M Sell
386,263
-85,029
-18% -$1.2M 0.06% 527
2024
Q4 		$6.23M Buy
471,292
+437,859
+1,310% +$7.49M 0.07% 442
2024
Q3 		$644K Sell
33,433
-60,473
-64% -$1.25M 0.01% 1189
2024
Q2 		$1.93M Buy
93,906
+19,314
+26% +$404K 0.03% 767
2024
Q1 		$1.78M Sell
74,592
-68,922
-48% -$1.54M 0.04% 696
2023
Q4 		$3.1M Buy
+143,514
New +$2.21M 0.07% 406
2023
Q3 		– Sell
-65,657
Closed -$1.37M – 1798
2023
Q2 		$1.37M Buy
65,657
+21,678
+49% +$451K 0.04% 642
2023
Q1 		$929K Buy
43,979
+33,436
+317% +$832K 0.03% 763
2022
Q4 		$268K Buy
+10,543
New +$246K 0.01% 1139
2021
Q1 		– Sell
-14,997
Closed -$334K – 1437
2020
Q4 		$334K Sell
14,997
-13,312
-47% -$276K 0.04% 634
2020
Q3 		$418K Buy
28,309
+10,874
+62% +$166K 0.03% 777
2020
Q2 		$258K Buy
+17,435
New +$266K 0.02% 953
2018
Q1 		– Sell
-40,274
Closed -$353K – 1354
2017
Q4 		$353K Buy
40,274
+28,923
+255% +$286K 0.04% 668
2017
Q3 		$133K Buy
+11,351
New +$139K 0.03% 700
2017
Q2 		– Sell
-20,595
Closed -$283K – 1136
2017
Q1 		$283K Buy
+20,595
New +$214K 0.04% 784

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Trexquant Investment's SNDX Position: Q2 2026 in Review

Trexquant Investment increased its Syndax Pharmaceuticals (SNDX) stake by 27% in Q2 2026, buying an estimated $1.13M and bringing the position to 255,949 shares worth $5.6M. The position accounts for 0.03% of the portfolio, ranked #696.

Trexquant Investment first reported a position in SNDX in Q1 2017 and has held it in 18 quarters since. The position peaked at $6.23M in Q4 2024. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Trexquant Investment held 255,949 shares of Syndax Pharmaceuticals worth $5.6M as of Q2 2026.
  • Trexquant Investment bought 54,172 Syndax Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Syndax Pharmaceuticals made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #696 holding.
  • Trexquant Investment first reported a position in Syndax Pharmaceuticals in Q1 2017 and has held it in 18 quarters since.
  • Trexquant Investment's Syndax Pharmaceuticals position peaked at $6.23M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.